These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6201588

  • 1. Selection of strongly immunogenic "tum-" variants from tumors at high frequency using 5-azacytidine.
    Frost P, Liteplo RG, Donaghue TP, Kerbel RS.
    J Exp Med; 1984 May 01; 159(5):1491-501. PubMed ID: 6201588
    [Abstract] [Full Text] [Related]

  • 2. Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.
    Kerbel RS, Frost P, Liteplo R, Carlow DA, Elliott BE.
    J Cell Physiol Suppl; 1984 May 01; 3():87-97. PubMed ID: 6205005
    [Abstract] [Full Text] [Related]

  • 3. Increased frequency of immunogenic variants obtained by repeated mutagen treatment of mouse mastocytoma P815.
    Marchand M, Caspar P, Boon T.
    Eur J Cancer Clin Oncol; 1983 Nov 01; 19(11):1529-37. PubMed ID: 6196202
    [Abstract] [Full Text] [Related]

  • 4. Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.
    Fuschiotti P, Fioretti MC, Romani L, Puccetti P.
    Cancer Immunol Immunother; 1989 Nov 01; 29(2):139-43. PubMed ID: 2470506
    [Abstract] [Full Text] [Related]

  • 5. In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.
    Elliott BE, Carlow DA, Ivimey L, Arnold M, Hampton N, Bosman P.
    Cancer Res; 1987 Sep 15; 47(18):4915-23. PubMed ID: 2441856
    [Abstract] [Full Text] [Related]

  • 6. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.
    Carlow DA, Kerbel RS, Feltis JT, Elliott BE.
    J Natl Cancer Inst; 1985 Aug 15; 75(2):291-301. PubMed ID: 2410653
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.
    Wölfel T, Van Pel A, De Plaen E, Lurquin C, Maryanski JL, Boon T.
    Immunogenetics; 1987 Aug 15; 26(3):178-87. PubMed ID: 3114137
    [Abstract] [Full Text] [Related]

  • 9. Effects of mutagens on the immunogenicity of tumor cells: comparison of cell surface changes induced by 5-azacytidine and N-methyl-N'-nitro-N-nitrosoguanidine.
    Altevogt P.
    Cancer Res; 1986 Jun 15; 46(6):2912-6. PubMed ID: 2421887
    [Abstract] [Full Text] [Related]

  • 10. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
    Maryanski JL, Szpirer J, Szpirer C, Boon T.
    Somatic Cell Genet; 1983 May 15; 9(3):345-57. PubMed ID: 6407125
    [Abstract] [Full Text] [Related]

  • 11. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
    Van Snick J, Maryanski J, Van Pel A, Parmiani G, Boon T.
    Eur J Immunol; 1982 Nov 15; 12(11):905-8. PubMed ID: 6818041
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL, Van Snick J, Cerottini JC, Boon T.
    Eur J Immunol; 1982 May 15; 12(5):401-6. PubMed ID: 6178607
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.
    Frost P, Kerbel RS, Bauer E, Tartamella-Biondo R, Cefalu W.
    Cancer Res; 1983 Jan 15; 43(1):125-32. PubMed ID: 6401163
    [No Abstract] [Full Text] [Related]

  • 18. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
    Maryanski JL, Marchand M, Uyttenhove C, Boon T.
    Int J Cancer; 1983 Jan 15; 31(1):119-23. PubMed ID: 6187698
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of genes encoding T cell defined tum- antigens.
    Van Pel A, De Plaen E, Lurquin C, Van den Eynde B, Lethé B, Hainaut P, Lemoine C, Boon T.
    Princess Takamatsu Symp; 1988 Jan 15; 19():255-63. PubMed ID: 3151988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.